Medline Inc/$MDLN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Medline Inc
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
- Ticker
- $MDLN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 45,000
- Headquarters
- Northfield, United States
- Website
- www.medline.com
Medline Inc Metrics
BasicAdvanced
$31B
44.94
$0.80
-
-
Price and volume
Market cap
$31B
52-week high
$50.88
52-week low
$31.49
Average daily volume
8.6M
Financial strength
Current ratio
4.333
Quick ratio
2.45
Long term debt to equity
0.658
Total debt to equity
0.659
Dividend payout ratio (TTM)
74.75%
Interest coverage (TTM)
1.72%
Profitability
EBITDA (TTM)
2,475
Gross margin (TTM)
25.09%
Net profit margin (TTM)
2.31%
Operating margin (TTM)
4.85%
Effective tax rate (TTM)
18.29%
Revenue per employee (TTM)
$670,000
Management effectiveness
Return on assets (TTM)
2.46%
Return on equity (TTM)
4.94%
Valuation
Price to earnings (TTM)
44.939
Price to revenue (TTM)
1.048
Price to book
2.71
Price to tangible book (TTM)
-3.12
Price to free cash flow (TTM)
20.286
Free cash flow yield (TTM)
4.93%
Free cash flow per share (TTM)
1.763
Growth
Revenue change (TTM)
12.12%
Earnings per share change (TTM)
998.36%
What the Analysts think about Medline Inc
Analyst ratings (Buy, Hold, Sell) for Medline Inc stock.
Analyst projections of the future price of Medline Inc stock.
Bulls say / Bears say
Medline is continuing to win share from new and existing customers. Second-quarter sales rose 11.6%, management lifted full-year organic sales guidance to 9%–10%, and first-half new customer signings reached more than 65% of its $1bn annual target. (BioSpace, The Motley Fool)
The Prime Vendor model still has room to expand geographically. Medline signed its first Prime Vendor agreement in Canada, giving it a route to apply its US supply-chain model to new hospitals and potentially build longer-term customer relationships outside its core domestic market. (Medline Newsroom, Medline Newsroom)
Investment in automation and digital supply-chain tools could improve service and productivity over time. Medline plans to pilot Symbotic’s AI-enabled warehouse robotics in 2027 and is rolling out its Mpower control tower, which uses supply and demand data to help customers identify disruptions and product alternatives earlier. (Medline Newsroom, PR Newswire)
Sales growth is not translating cleanly into profit. Q2 net sales rose 11.6% and first-half sales rose 11.1%, but first-half adjusted EBITDA grew only 1.9%, while management cut full-year EBITDA guidance to $3.3bn–$3.4bn despite raising its sales outlook. (BioSpace, The Motley Fool)
The Tracy distribution-centre fire created a major execution risk. The June blaze caused an estimated $336m of losses, and Medline expects a further $50m–$100m of Tracy-related costs in the second half, with some lease and labour inefficiencies becoming part of its ongoing cost base. (StockTitan, The Motley Fool)
The balance sheet leaves limited room for further setbacks. Medline reported $12.75bn of total debt and net leverage of 2.9 times at the end of the first half, so weaker margins or extra rebuilding costs could slow debt reduction and restrict financial flexibility. (StockTitan, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 18 Sept 2026.
Medline Inc Financial Performance
Revenues and expenses
Medline Inc Earnings Performance
Company profitability
Upcoming events
No upcoming events
Medline Inc News
AllArticlesVideos
MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations
Newsfile Corp5 days ago
Kaplan Fox is Investigating Medline Inc. (MDLN) for Investors Who Suffered Losses
Newsfile Corp7 days ago
Kaplan Fox Urges Investors of Medline Inc. (MDLN) with Losses to Contact the Firm
Newsfile Corp2 weeks ago
Funds containing Medline Inc
AllUSDEURGBP
Fund name | Fund size | $MDLN weighting |
|---|---|---|
SPDR MSCI World Health Care$WHEA | $708M | 0.16% |
Xtrackers MSCI World Health Care$XDWH | $4.1B | 0.16% |
Xtrackers MSCI World Health Care£XWHS | $4.1B | 0.16% |
Invesco MSCI World Equal Weight$MWEQ | $2B | 0.09% |
Invesco MSCI World Equal Weight£MWEP | $2B | 0.09% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.